We offer a novel approach to breast cancer classification, integrating imaging phenotypes with molecular typing, ER, PR, tumor size, histological grading, edema, and lymph node metastasis, these may have varying influences on the prognosis and survival outcomes in breast cancer patients. This evidence concerns the gene ESR1 and breast carcinoma.